| Literature DB >> 32843345 |
Matteo Vietri Rudan1, Ajay Mishra1,2, Christian Klose3, Ulrike S Eggert4, Fiona M Watt5.
Abstract
While the lipids of the outer layers of mammalian epidermis and their contribution to barrier formation have been extensively described, the role of individual lipid species in the onset of keratinocyte differentiation remains unknown. A lipidomic analysis of primary human keratinocytes revealed accumulation of numerous lipid species during suspension-induced differentiation. A small interfering RNA screen of 258 lipid-modifying enzymes identified two genes that on knockdown induced epidermal differentiation: ELOVL1, encoding elongation of very long-chain fatty acids protein 1, and SLC27A1, encoding fatty acid transport protein 1. By intersecting lipidomic datasets from suspension-induced differentiation and knockdown keratinocytes, we pinpointed candidate bioactive lipid subspecies as differentiation regulators. Several of these-ceramides and glucosylceramides-induced differentiation when added to primary keratinocytes in culture. Our results reveal the potential of lipid subspecies to regulate exit from the epidermal stem cell compartment.Entities:
Keywords: differentiation; epidermis; keratinocytes; lipidomics; lipids
Mesh:
Year: 2020 PMID: 32843345 PMCID: PMC7486749 DOI: 10.1073/pnas.2011310117
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205
Fig. 1.Keratinocyte lipid composition changes during suspension-induced differentiation. (A) Schematic overview of the experimental strategy and keratinocyte response to treatments (9). (B) Class-level variation of ceramides and hexosylceramides during suspension-induced keratinocyte differentiation, expressed as a percentage of the total sample lipids. Error bars indicate SDs. (C) Heat map representation and two-dimensional (2D) clustering of samples (Euclidean distance and complete-linkage clustering) based on the Z-scores of all lipid species (y axis) identified in the lipidomic analysis of suspension-induced keratinocyte differentiation; different time points/conditions are shown along the x axis; dendrogram branches are color-coded according to the schematic in A. (D) Sample variation along the first two principal components. (E) Separation along three components by sPLS after fitting the samples to the model shown in A. (F) Contribution of the 50 most discriminant lipid species to the separation along the second (Upper panel) and third (Lower panel) components of sPLS. Error bars indicate SDs; P values are calculated using multiple t tests with Holm–Sidak adjustment for multiple comparisons (*P < 0.05).
Fig. 2.siRNA-mediated knockdown of lipid-modifying enzymes can affect keratinocyte differentiation. (A) Heat map representation of the Z-scores of involucrin levels in 258 lipid-modifying enzyme knockdowns (y axis) after 2D clustering of samples (x axis) (Euclidean distance and complete-linkage clustering). (B) Volcano plot of the screening results to identify hits based on statistical significance (P < 0.05) and fold change (FC) with respect to nontargeting siRNA controls included in each individual plate (FC < 0.6 for differentiation inhibition; FC > 2.5 for differentiation induction). Validation of differentiation-inhibiting (C) and differentiation-inducing (D) knockdowns by qPCR of differentiation markers (Upper) and immunofluorescence staining of involucrin (Lower); p.t.: posttransfection. Colony formation assay validation of differentiation-inhibiting (E) and differentiation-inducing (F) knockdowns with representative images for each siRNA. Error bars indicate SDs; P values are calculated using Dunnet’s multiple comparison test (*P < 0.05, **P < 0.01).
Fig. 3.ELOVL1 or SLC27A1 knockdowns promote accumulation of specific lipid molecules. (A) Heat map representation and 2D clustering (Euclidean distance and complete-linkage clustering) of the Z-scores of all lipid species identified in the lipidomic analysis of differentiation-inducing knockdowns and control keratinocytes. (B) Sample variation along the first two principal components. (C and D) Sample separation along the first two components by sPLS of the 48 h (C) and 72 h (D) samples. (E and F) Contribution of the 50 most discriminant lipid species to the separation along the first and second components of sPLS for the 48 h (E) and 72 h (F) samples.
Fig. 4.Specific lipid molecules can induce keratinocyte differentiation in culture. (A) Overlap between the discriminant lipid sets enriched during ELOVL1 knockdown, SLC27A1 knockdown, or suspension-induced keratinocyte differentiation. (B) Keratinocyte response to different doses of ceramides and glucosylceramides identified in the ELOVL1 intersection enriched lipid set (teal), in the SLC27A1 intersection lipid set (yellow), in the suspension-induced differentiation enriched lipid set (orange), or in no set (white box). Error bars indicate SDs, P values are calculated using one-way ANOVA with Dunnett’s multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001), comparing each lipid treatment to vehicle-treated cells (1% ethanol, represented by a dashed line in the graphs). (C) Effect of bioactive lipid treatments on the colony formation ability of keratinocytes. Shown are the total number of colonies per well (dark purple bars) as well as the number of abortive colonies (magenta bars). Representative images for each treatment are shown below the bar plot. Error bars indicate SDs, P values are calculated using one-way ANOVA with Dunnett’s multiple comparison test (colony number) or the Kruskal–Wallis test with Dunn’s multiple comparison test (colony size) (*P < 0.05, ***P < 0.001).
Lipid molecules enriched both upon ELOVL1 or SLC27A1 knockdown and upon suspension-induced differentiation of primary human keratinocytes
| Knockdown | Lipid species | Max fold change | Tested lipid | Differentiation induction |
| siELOVL1 | Ceramide – 32:1:2 (C14:0 Cer) | 1.7 (72 h) | C14:0 ceramide | Yes |
| siELOVL1 | Ceramide – 34:1:2 (C16:0 Cer) | 1.7 (48 h) | C16:0 ceramide | Yes |
| siELOVL1 | Ceramide – 34:2:2 (C16:1 Cer) | 1.5 (72 h) | — | — |
| siELOVL1 | Ceramide – 38:1:2 (C20:0 Cer) | 8.3 (72 h) | — | — |
| siELOVL1 | Ceramide – 40:1:2 (C22:0 Cer) | 1.3 (72 h) | C24:0 ceramide (accumulated in suspension-differentiated cells) | Yes |
| siELOVL1 | Ceramide – 40:2:2 (C22:1 Cer) | 1.7 (72 h) | — | — |
| siELOVL1 | Hexosylceramide – 34:1:2 (C16:0 HexCer) | 1.5 (72 h) | — | — |
| siELOVL1 | Hexosylceramide – 36:1:2 (C18:0 HexCer) | Accumulated | C18:0 glucosylceramide | Yes |
| siELOVL1 | Hexosylceramide – 38:1:2 (C20:0 HexCer) | Accumulated | — | — |
| siELOVL1 | Hexosylceramide – 40:1:2 (C22:0 HexCer) | 3 (72 h) | — | — |
| siELOVL1 | Hexosylceramide – 40:2:2 (C22:1 HexCer) | Accumulated | ||
| siELOVL1 | Phosphatidylcholine – 17:0:0;17:1:0 | 3.7 (48 h) | — | — |
| siELOVL1 | Phosphatidylcholine – 18:0:0;18:1:0 | 1.1 (72 h) | — | — |
| siELOVL1 | Phosphatidylcholine – 18:0:0;18:2:0 | 2 (72 h) | — | — |
| siELOVL1 | Phosphatidylcholine – 18:1:0;18:1:0 | 1.2 (72 h) | — | — |
| siELOVL1 | Phosphatidylcholine – 18:1:0;18:2:0 | 1.1 (48 h) | — | — |
| siELOVL1 | Phosphatidylcholine – 18:2:0;18:2:0 | 1.3 (48 h) | — | — |
| siELOVL1 | Phosphatidylethanolamine ether – 18:1:0;18:1:0 | 1.05 (48 h) | ||
| siELOVL1 | Phosphatidylethanolamine ether – 18:1:0;20:3:0 | 1.2 (72 h) | — | — |
| siELOVL1 | Phosphatidylethanolamine ether – 18:1:0;20:4:0 | 1.2 (72 h) | — | — |
| siELOVL1 | Phosphatidylinositol – 16:1:0;20:4:0 | Accumulated | — | — |
| siELOVL1 | Phosphatidylserine – 14:0:0;18:1:0 | 1.8 (48 h) | — | — |
| siELOVL1 | Phosphatidylserine – 16:1:0;20:0:0 | 3.2 (48 h) | ||
| siELOVL1 | Phosphatidylserine – 18:1:0;20:0:0 | 1.9 (48 h) | — | — |
| siELOVL1 | Phosphatidylserine – 18:2:0;20:0:0 | Accumulated | — | — |
| siELOVL1 | Phosphatidylserine – 18:2:0;22:1:0 | 3.7 (72 h) | — | — |
| siSLC27A1 | Hexosylceramide – 42:2:2 (C24:1 HexCer) | 1.1 (72 h) | C24:1(Δ9) glucosylceramide | Yes |
| siSLC27A1 | Phosphatidic acid – 16:0:0;18:2:0 | 3.2 (48 h) | — | — |
| siSLC27A1 | Phosphatidylcholine – 16:1:0;16:1:0 | 1.1 (48 h) | — | — |
| siSLC27A1 | Phosphatidylcholine – 18:0:0;20:3:0 | 1.3 (48 h) | — | — |
| siSLC27A1 | Phosphatidylcholine ether – 16:1:0;16:1:0 | 1.2 (72 h) | — | — |
| siSLC27A1 | Phosphatidylcholine ether – 16:1:0;20:4:0 | 4.2 (72 h) | — | — |
| siSLC27A1 | Phosphatidylcholine ether – 18:1:0;16:1:0 | 1.3 (72 h) | — | — |
| siSLC27A1 | Phosphatidylcholine ether – 18:1:0;20:4:0 | 1.1 (72 h) | — | — |
| siSLC27A1 | Phosphatidylethanolamine ether – 16:1:0;20:3:0 | 1.1 (72 h) | — | — |
| siSLC27A1 | Phosphatidylglycerol – 16:1:0;18:0:0 | Accumulated | — | — |
| siSLC27A1 | Phosphatidylglycerol – 18:2:0;18:2:0 | 2.4 (72 h) | — | — |
| siSLC27A1 | Phosphatidylglycerol – 18:2:0;20:3:0 | 7 (72 h) | — | — |
| siSLC27A1 | Phosphatidylinositol – 16:2:0;18:0:0 | Accumulated | — | — |
| siSLC27A1 | Phosphatidylinositol – 18:2:0;20:2:0 | 4 (48 h) | — | — |
| siSLC27A1 | Phosphatidylserine – 16:1:0;18:1:0 | 1.3 (48 h) | — | — |
| siSLC27A1 | Phosphatidylserine – 18:0:0;19:1:0 | Accumulated | — | — |
Lipids are annotated as “Class – Carbon chain length: Unsaturations: Hydroxylations.” For sphingolipids, the numbers refer to the total in the molecule; for phospholipids, individual lengths of the two fatty acid moieties are reported. The alternative notation used for sphingolipids refers to the carbon chain length of their fatty acid moiety and its number of unsaturations.
Fold changes are calculated based on the percentage picomole relative to total sample lipids.
A numeric value could not be calculated due to undetectable levels in the control.